Search clinical trials for: Buserelin

Total 24 results

NRG Oncology
National Cancer Institute (NCI)

Recruiting

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score

Prostate Adenocarcinoma

United States, Canada
NRG Oncology
National Cancer Institute (NCI)

Recruiting

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Prostate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8

United States, Canada
Proton Collaborative Group

Recruiting

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

Prostate Cancer

United States
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology; Cancer and Leukemia Group B

Active, not recruiting

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Prostate Cancer

United States, Canada, China, Israel
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Active, not recruiting

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

Prostate Cancer

United States, Canada
NCIC Clinical Trials Group

Terminated

Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer (DART)

Prostate Cancer

Canada
NCIC Clinical Trials Group

Completed

Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer

Prostate Cancer

Canada
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Active, not recruiting

Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

Prostate Cancer

United States, Canada
NCIC Clinical Trials Group
National Cancer Institute (NCI); Southwest Oncology Group

Completed

Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer

Prostate Cancer

Canada
South Plains Oncology Consortium

Terminated

Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer

Ovarian Cancer | Cancer of the Ovary | Primary Peritoneal Carcinoma | Ovary Neoplasms | Cancer of Ovary

United States
NCIC Clinical Trials Group
National Cancer Institute (NCI); Medical Research Council; Eastern Cooperative... and other collaborators

Completed

Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer

Prostate Cancer

Canada
Ferring Pharmaceuticals

Completed

Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists. (ProComD)

Advanced Prostate Cancer

Germany
Institut Paoli-Calmettes
Novartis

Terminated

Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate Cancer (NCMPC-BKM)

Non Castrate Metastatic Prostate Cancer

France
Andros Day Surgery Clinic

Terminated

Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles

In Vitro Fertilization | Ovarian Stimulation

Italy
Medical University of Vienna

Suspended

Efficacy of Ovarian Stimulation Based on FSHR Genotype Status

Sterility

Austria
University of British Columbia

Unknown

Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy

Prostate Cancer

Canada
Yazd Research & Clinical Center for Infertility

Completed

Antagonist/Letrozole in Poor Responders

Ovarian Stimulation

Iran, Islamic Republic of
Regionshospitalet Viborg, Skive

Completed

Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles

OHSS (Ovarian Hyperstimulation)

Denmark
European Hospital

Unknown

The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation Protocol

Embryo's Genetic and Chromosomal Quality

Italy
Yazd Medical University
Yazd Research & Clinical Center for Infertility

Completed

Mild Stimulation Protocol Versus Microdose Gonadotropin-releasing Hormone Agonist Flare up Protocol in Poor Responders

Pregnancy

Iran, Islamic Republic of
Yazd Research & Clinical Center for Infertility

Unknown

Replacement of Fresh Embryo Transfers (ETs) by Frozen Embryo Transfers (FETs) Using Vitrification

In Vitro Fertilization

Iran, Islamic Republic of
Yazd Research & Clinical Center for Infertility

Completed

Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist

Ovarian Stimulation

Iran, Islamic Republic of
Yazd Research & Clinical Center for Infertility

Unknown

Agonist Gonadotropin-Releasing Hormone (GnRH) Versus Antagonist GnRH

Infertility

Iran, Islamic Republic of
Tehran University of Medical Sciences

Completed

Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin

Infertility

Iran, Islamic Republic of

3

Subscribe